Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Wat betekent COVID-19 voor de MS-zorg?
apr 2020 | Multipele Sclerose